FDA

Concerns are mounting about the health of lawmakers and other people in the Capitol last week, after the first member to test positive for the Coronavirus (COVID-19) since Wednesday’s chaos, said she believed she was exposed in a crowded hiding place with hundreds of other legislators.

Bioresources Development Group (BDG) chairman, Prof. Maurice Iwu has restated the efficacy of herbal medicine in the treatment of the COVID-19 cases as the virus enters variant stage globally.

Dr. Arthur, speaking in an interview with Berla Mundi on the New Day show on TV3 on December 31, stated that the much awaited vaccines for the COVID-19 pandemic should not be confused with drugs that will cure the virus but rather just a vaccine which is not hundred percent cure-proof for the virus.

The U.S. Food and Drug Administration (FDA) on Friday approved for emergency use a second coronavirus vaccine produced by American biotechnology company, Moderna.

Johnson & Johnson said on Thursday it has enrolled about 45,000 participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate and that it expects interim data by late-January.

A panel of outside advisers to the U.S. Food and Drug Administration on Thursday overwhelmingly endorsed emergency use of Moderna Inc’s coronavirus vaccine, virtually assuring a second option for protecting against COVID-19 for a pandemic ravaged nation.

An independent committee of experts recommended that the Food and Drug Administration authorize the Moderna COVID-19 vaccine for people 18 and older. This is the second COVID-19 vaccine to go before the committee — the first, made by Pfizer and BioNTech, was authorized last week.

Dino Melaye, a former Nigerian senator, has urged Nigerians not to be vaccinated against the coronavirus, which has killed thousands across the world and almost two thousand people in Nigeria.

The analysis by the Food and Drug Administration’s (FDA) means it could become the second coronavirus vaccine to be allowed in the US.

Moderna Inc’s COVID-19 vaccine appeared to be set for regulatory authorization this week after U.S. Food and Drug Administration staff members did not raise any major new concerns about it in documents released on Tuesday.

The European Medicines Agency (EMA) is set to approve its first COVID-19 vaccine on Dec. 23, a German government source told Reuters on Tuesday, putting EU countries on track to start to catch up with the United States and Britain, where immunisation campaigns are under way.

Outgoing U.S. President Donald Trump on Sunday night said he was not scheduled to be vaccinated against the Coronavirus (COVID-19), after a media report indicated he could receive a jab as early as Monday.

The first shipments of COVID-19 vaccine left on trucks and planes early on Sunday, kicking off a historic effort to stop a surging pandemic that is claiming more than 2,400 lives a day in the United States.

Even as United States have continued to harvest huge numbers of deaths and hospitalization occasioned by novel Coronavirus (Covid-19) infections, hope has come for victims as the first Covid-19 vaccines shipment in American soil have left Kalamazoo factory of one of the world’s drugs manufacturing companies Pfizer.

The US public will start receiving the Pfizer/BioNTech coronavirus vaccine from Monday after it was authorised for emergency use, officials say.

The KAD ICT Hub, established to bridge the digital gap in Kaduna State, said that it had trained 10,000 residents of the state in different digital skills from inception in 2017 to 2020.

An independent committee of experts recommended Thursday that the Food and Drug Administration authorize the Pfizer and BioNTech COVID-19 vaccine for people over the age of 16. Now, the FDA will decide whether to follow that recommendation. The agency could announce a decision within days. If they do authorize the vaccine, health care workers could begin receiving the shots almost immediately.

Pfizer Inc has scaled the next hurdle in the race to get its COVID-19 vaccine approved for emergency use after the U.S. Food and Drug Administration (FDA) released documents that raised no new issues about its safety or efficacy.